Last $0.08 USD
Change Today -0.0065 / -7.30%
Volume 2.1M
ISCO On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrey Semechkin Ph.D.

Co-Chairman and Chief Executive Officer, International Stem Cell Corporation
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 1 different industries.

See Board Relationships
54$281,492
As of Fiscal Year 2013

Background*

Prof. Dr. Andrey Semechkin, Ph.D., has been the Chief Executive Officer of International Stem Cell Corporation since November 15, 2009. Prof. Dr. Semechkin is the Owner of AR Partners, LLC. Prof. Dr. Semechkin served as President of International Stem Cell Corporation until October 6, 2011. He served as Executive Vice President of Strategy and Science of International Stem Cell Corporation. Prof. Dr. Semechkin served as an Executive Vice President of International Stem ...

Read Full Background

Corporate Headquarters*

5950 Priestly Drive
Carlsbad, California 92008

United States

Phone: 760-940-6383
Fax: 760-476-0600

Board Members Memberships*

2008-Present
Co-Chairman and Chief Executive Officer

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary$258,457
Total Annual Compensation$258,457

Stock Options*

Total Number of Options4,639,000

Total Compensation*

Total Annual Cash Compensation$258,457
Total Short Term Compensation$258,457
Total Calculated Compensation$281,492
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISCO:US $0.08 USD -0.0065

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Dominick C. Colangelo Esq.Chief Executive Officer, President, Treasurer and Director
Aastrom Biosciences, Inc.
$358.3K
Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
$406.6K
Martin M. McGlynn Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc
StemCells Inc.
$835.8K
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$467.3K
Mike Tomas Chief Executive Officer, President, Principal Financial Officer, Principal Accounting Officer, Director and Member of Advisory Board
Bioheart, Inc.
$766.7K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERNATIONAL STEM CELL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.